SBHMY
Price
$8.34
Change
-$0.71 (-7.85%)
Updated
Dec 16 closing price
TENX
Price
$5.52
Change
-$0.29 (-4.99%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

SBHMY vs TENX

Header iconSBHMY vs TENX Comparison
Open Charts SBHMY vs TENXBanner chart's image
Sino Biopharmaceutical
Price$8.34
Change-$0.71 (-7.85%)
Volume$161
CapitalizationN/A
Tenax Therapeutics
Price$5.52
Change-$0.29 (-4.99%)
Volume$100
CapitalizationN/A
SBHMY vs TENX Comparison Chart
Loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SBHMY vs. TENX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHMY is a Hold and TENX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SBHMY: $8.34 vs. TENX: $5.52)
Brand notoriety: SBHMY and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SBHMY: 84% vs. TENX: 76%
Market capitalization -- SBHMY: $7.52B vs. TENX: $18.85M
SBHMY [@Biotechnology] is valued at $7.52B. TENX’s [@Biotechnology] market capitalization is $18.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBHMY’s FA Score shows that 1 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • SBHMY’s FA Score: 1 green, 4 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than SBHMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SBHMY’s TA Score shows that 1 TA indicator(s) are bullish while TENX’s TA Score has 4 bullish TA indicator(s).

  • SBHMY’s TA Score: 1 bullish, 3 bearish.
  • TENX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both SBHMY and TENX are a bad buy in the short-term.

Price Growth

SBHMY (@Biotechnology) experienced а -7.90% price change this week, while TENX (@Biotechnology) price change was -8.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

TENX is expected to report earnings on Apr 03, 2023.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($7.52B) has a higher market cap than TENX($18.9M). SBHMY YTD gains are higher at: -7.742 vs. TENX (-74.873). SBHMY has higher annual earnings (EBITDA): 6.98B vs. TENX (-14.53M). SBHMY has higher revenues than TENX: SBHMY (26.2B) vs TENX (0).
SBHMYTENXSBHMY / TENX
Capitalization7.52B18.9M39,794%
EBITDA6.98B-14.53M-48,031%
Gain YTD-7.742-74.87310%
P/E Ratio25.76N/A-
Revenue26.2B0-
Total CashN/A98.3M-
Total DebtN/A279K-
FUNDAMENTALS RATINGS
SBHMY vs TENX: Fundamental Ratings
SBHMY
TENX
OUTLOOK RATING
1..100
9519
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
5638
P/E GROWTH RATING
1..100
61100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (1) in the null industry is in the same range as TENX (8) in the Medical Specialties industry. This means that SBHMY’s stock grew similarly to TENX’s over the last 12 months.

SBHMY's Profit vs Risk Rating (100) in the null industry is in the same range as TENX (100) in the Medical Specialties industry. This means that SBHMY’s stock grew similarly to TENX’s over the last 12 months.

TENX's SMR Rating (95) in the Medical Specialties industry is in the same range as SBHMY (97) in the null industry. This means that TENX’s stock grew similarly to SBHMY’s over the last 12 months.

TENX's Price Growth Rating (38) in the Medical Specialties industry is in the same range as SBHMY (56) in the null industry. This means that TENX’s stock grew similarly to SBHMY’s over the last 12 months.

SBHMY's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for TENX (100) in the Medical Specialties industry. This means that SBHMY’s stock grew somewhat faster than TENX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SBHMYTENX
RSI
ODDS (%)
Bullish Trend 2 days ago
43%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGNX3.340.11
+3.41%
MacroGenics
CCL25.72-0.19
-0.73%
Carnival Corp
PLAG2.49-0.04
-1.58%
Planet Green Holdings Corp
PBH80.39-1.60
-1.95%
Prestige Consumer Healthcare
USNA34.62-1.66
-4.58%
USANA Health Sciences

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with TENX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
TENX - SBHMY
42%
Loosely correlated
-4.99%
SYBX - SBHMY
34%
Loosely correlated
-5.52%
BTAI - SBHMY
32%
Poorly correlated
-8.95%
CLRPF - SBHMY
24%
Poorly correlated
+6.52%
TPIA - SBHMY
22%
Poorly correlated
+6.38%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
-4.99%
AVXL - TENX
47%
Loosely correlated
-5.65%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
-4.93%
ADVM - TENX
34%
Loosely correlated
-8.03%
LOGC - TENX
33%
Loosely correlated
-4.04%
More